Figure 3. Efficacy of sorafenib for mortality rate.

Shows forest plot of risk ratio of mortality rate of patients with hepatocellular carcinoma after resection who treated with sorafenib versus control. Subgroup analysis of 5 studies according to study typewere conducted because of the high heterogeneity when pooling all data. Data of each subgroup were pooled using fixed-effects model. Studies are sorted by publication year.